Christopher J. Novosad

Array ( [id] => 7677715 [patent_doc_number] => 20040152111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Compositions and methods for diagnosing and treating mood disorders' [patent_app_type] => new [patent_app_number] => 10/701263 [patent_app_country] => US [patent_app_date] => 2003-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 24597 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152111.pdf [firstpage_image] =>[orig_patent_app_number] => 10701263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7252437 [patent_doc_number] => 20040259211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Rapid induction of Alzheimer\'s amyloid plaque formation by sulfated glycosaminoglycans' [patent_app_type] => new [patent_app_number] => 10/698259 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11865 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259211.pdf [firstpage_image] =>[orig_patent_app_number] => 10698259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7322367 [patent_doc_number] => 20040136993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Prevention and treatment of synucleinopathic disease' [patent_app_type] => new [patent_app_number] => 10/699517 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23901 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20040136993.pdf [firstpage_image] =>[orig_patent_app_number] => 10699517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7409853 [patent_doc_number] => 20040176313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Inhibitors of Src kinase for use in alzheimer\'s disease' [patent_app_type] => new [patent_app_number] => 10/691079 [patent_app_country] => US [patent_app_date] => 2003-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3924 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176313.pdf [firstpage_image] =>[orig_patent_app_number] => 10691079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 211364 [patent_doc_number] => 07622270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Methods of isolating dopaminergic neuron precursor cells' [patent_app_type] => utility [patent_app_number] => 10/532264 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17907 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622270.pdf [firstpage_image] =>[orig_patent_app_number] => 10532264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7307359 [patent_doc_number] => 20040141947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Method for treatment of demyelinating central nervous system disease' [patent_app_type] => new [patent_app_number] => 10/687576 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3883 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20040141947.pdf [firstpage_image] =>[orig_patent_app_number] => 10687576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7088983 [patent_doc_number] => 20050009096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Method for diagnosis and prognosis of multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 10/683451 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24514 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009096.pdf [firstpage_image] =>[orig_patent_app_number] => 10683451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136696 [patent_doc_number] => 20050181450 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Novel inositol 1,4,5-trisphosphate (IP3) receptor-binding protein and an IP3 indicator' [patent_app_type] => utility [patent_app_number] => 10/683610 [patent_app_country] => US [patent_app_date] => 2003-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15165 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181450.pdf [firstpage_image] =>[orig_patent_app_number] => 10683610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675744 [patent_doc_number] => 20040126374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Sustained treatment of type 1 diabetes after expression of predisposition markers' [patent_app_type] => new [patent_app_number] => 10/681788 [patent_app_country] => US [patent_app_date] => 2003-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23042 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126374.pdf [firstpage_image] =>[orig_patent_app_number] => 10681788 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5912339 [patent_doc_number] => 20060127401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Screening method' [patent_app_type] => utility [patent_app_number] => 10/530450 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 5646 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127401.pdf [firstpage_image] =>[orig_patent_app_number] => 10530450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432084 [patent_doc_number] => 07968515 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Protein S protects the nervous system from injury' [patent_app_type] => utility [patent_app_number] => 10/529748 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 15 [patent_no_of_words] => 11329 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968515.pdf [firstpage_image] =>[orig_patent_app_number] => 10529748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7269839 [patent_doc_number] => 20040058357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'System and method for assaying drugs' [patent_app_type] => new [patent_app_number] => 10/432131 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 24911 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058357.pdf [firstpage_image] =>[orig_patent_app_number] => 10432131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359570 [patent_doc_number] => 07485449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Nucleic acids encoding sodium channel scn3a alpha subunits' [patent_app_type] => utility [patent_app_number] => 10/664422 [patent_app_country] => US [patent_app_date] => 2003-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 7 [patent_no_of_words] => 18061 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485449.pdf [firstpage_image] =>[orig_patent_app_number] => 10664422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6917678 [patent_doc_number] => 20050095239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Methods and compositions for treating Alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 10/664414 [patent_app_country] => US [patent_app_date] => 2003-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12729 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095239.pdf [firstpage_image] =>[orig_patent_app_number] => 10664414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177752 [patent_doc_number] => 07655460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Nucleic acids encoding sodium channel SCN1A alpha subunit proteins with mutations associated with epilepsy' [patent_app_type] => utility [patent_app_number] => 10/664423 [patent_app_country] => US [patent_app_date] => 2003-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 7 [patent_no_of_words] => 18062 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655460.pdf [firstpage_image] =>[orig_patent_app_number] => 10664423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7269410 [patent_doc_number] => 20040057928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Use of il-6r/il-6 chimera in huntington\'s disease' [patent_app_type] => new [patent_app_number] => 10/380427 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11682 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20040057928.pdf [firstpage_image] =>[orig_patent_app_number] => 10380427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905619 [patent_doc_number] => 20050101014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury' [patent_app_type] => utility [patent_app_number] => 10/661105 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 16438 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101014.pdf [firstpage_image] =>[orig_patent_app_number] => 10661105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995312 [patent_doc_number] => 20070010657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model uses in human neurological diseases' [patent_app_type] => utility [patent_app_number] => 10/527769 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 52164 [patent_no_of_claims] => 139 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010657.pdf [firstpage_image] =>[orig_patent_app_number] => 10527769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5747428 [patent_doc_number] => 20060110359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Cellular delivery of natriuretic peptides' [patent_app_type] => utility [patent_app_number] => 10/526538 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9962 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110359.pdf [firstpage_image] =>[orig_patent_app_number] => 10526538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467612 [patent_doc_number] => 20040120891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Compounds for intracellular delivery of therapeutic moieties to nerve cells' [patent_app_type] => new [patent_app_number] => 10/655756 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11942 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20040120891.pdf [firstpage_image] =>[orig_patent_app_number] => 10655756 [rel_patent_id] =>[rel_patent_doc_number] =>)